Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer

Dendritic cell-based immunotherapy in ovarian cancer

Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma

A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside

A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer

Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer

Dendritic cell-based tumor vaccinations in epithelial ovarian cancer: a systematic review

Immunotherapy in ovarian cancer

Successful treatment of advanced ovarian cancer with thermochemotherapy and adjuvant immune therapy

Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease